Dr Christopher Rapuano comments on a new study showing that appropriately managing common corneal surface irregularities can greatly aid in improving refractive outcomes after cataract surgery. Medscape Ophthalmology
Tag: Viewpoint
New Fixed-Dose, Once-Daily Combo Eyedrop Shows Efficacy in Glaucoma
There is a sound rationale why combining netarsudil and latanoprost would work so well. Medscape Ophthalmology
Is Treat-and-Extend Truly Effective for Diabetic Macular Edema?
A 2-year study is the latest to highlight this approach’s benefits, but its design also overlooks an important comparative treatment. Medscape Ophthalmology
Pupil Expansion Rings Have Advantages in Cataract Surgery
Dr Sumit (Sam) Garg on how a recent case series underlines their relative benefits compared with iris hooks. Medscape Ophthalmology
What’s the Mediterranean Diet’s Value in AMD?
A recent pooled analysis makes a compelling case for this diet’s protective role, but establishing a direct causal role remains elusive. Medscape Ophthalmology
What’s the Mediterranean Diet’s Value in AMD?
A recent pooled analysis makes a compelling case for this diet’s protective role, but establishing a direct causal role remains elusive. Medscape Ophthalmology
Are Modest Gains From Two-Stent Glaucoma Surgery Worth Pursuing?
It may not replace trabeculectomy yet, but there is value associated with this second-generation microinvasive surgery. Medscape Ophthalmology
Don’t Miss This Risk in Female Cataract Surgery Patients
Dr Sumit (Sam) Garg takes a closer look at the unique intraoperative risks that floppy iris syndrome poses to female patients compared with their male counterparts. Medscape Ophthalmology
High-Dose Steroids: Worth the Risk in Bacterial Keratitis?
Dr Christopher Rapuano on why, despite its limitations, a new study provides convincing evidence that this treatment approach is warranted. Medscape Ophthalmology
Why Patients Keep Crucial Info From Clinicians
A recent survey had some surprising revelations as to why patients don’t divulge health information. Can its findings help us increase disclosure? Medscape Optometry
Two-Stent Injection Lowers IOP in Various Glaucoma Types
Dr Shuchi Patel on the latest results with the trabecular microbypass iStent inject. Medscape Ophthalmology
Crosslinking: Is Using an Epi-On Technique Effective?
Dr Sumit (Sam) Garg on a new study that lends support to the much-debated procedure. Medscape Ophthalmology
Diabetes, Complications Reduce Odds of Successful DSEK
Dr Christopher Rapuano on the latest data from the Cornea Preservation Time Study. Medscape Ophthalmology
Anti-VEGF Efficacy in DME: Early Response Is Not Destiny
New data from Protocol T shows that eyes with poor 12-week response often had good vision at 2 years without switching therapies. Medscape Ophthalmology
Errors in Diagnosing Optic Neuritis–How Can We Fix Them?
A new study sheds light on the alarmingly high rate of misdiagnosis–and misallocated treatments–in this acute condition. Medscape Optometry
Netarsudil Lowers IOP, but When Should It Be Given?
Findings from the ROCKET trials shed light on –and also raise questions about –this newly approved medication for glaucoma. Medscape Ophthalmology
Corneal Transplantation Failed. What Now?
Dr Christopher Rapuano on a new study comparing long-term outcomes between penetrating and endothelial keratoplasty for repeat corneal transplantation. Medscape Ophthalmology
Don’t Overlook Ocular Surface Disease Before Cataract Surgery
Dr Sumit (Sam) Garg on the risks of failing to preoperatively diagnose this highly prevalent condition. Medscape Ophthalmology
(S)pot Check on Alternative Treatments for Glaucoma
Does marijuana, gingko biloba, or bilberry effectively manage symptoms of glaucoma? Medscape Ophthalmology
Anti-VEGF Effective in Persistent Diabetic Macular Edema
A recent analysis associated three different anti-VEGF agents with meaningful vision gains through 2 years of follow-up. Medscape Ophthalmology